UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Linde
LIN
|
+$940M |
| 2 |
Abbott
ABT
|
+$911M |
| 3 |
Amgen
AMGN
|
+$800M |
| 4 |
Pinduoduo
PDD
|
+$336M |
| 5 |
Advanced Micro Devices
AMD
|
+$289M |
Top Sells
| 1 |
Ametek
AME
|
+$485M |
| 2 |
Microsoft
MSFT
|
+$301M |
| 3 |
Amazon
AMZN
|
+$236M |
| 4 |
VMW
VMware, Inc
VMW
|
+$205M |
| 5 |
TSMC
TSM
|
+$143M |
Sector Composition
| 1 | Technology | 28.1% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.1% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Madrigal Pharmaceuticals
MDGL
$9.63B
| $3.75M | ﹤0.01% |
+15,472
| New | +$3.75M |
|
1302
Navient
NAVI
$1.28B
| $3.75M | ﹤0.01% |
234,333
+19,524
| +9% | +$312K |
|
1303
ABM Industries
ABM
$2.8B
| $3.74M | ﹤0.01% |
83,170
+4,157
| +5% | +$187K |
|
1304
Tandem Diabetes Care
TNDM
$829M
| $3.73M | ﹤0.01% |
91,953
+3,585
| +4% | +$146K |
|
1305
ChargePoint
CHPT
$242M
| $3.72M | ﹤0.01% |
17,776
-1,193
| -6% | -$250K |
|
1306
CRISPR Therapeutics
CRSP
$5.12B
| $3.72M | ﹤0.01% |
82,286
+6,380
| +8% | +$289K |
|
1307
Atlantic Union Bankshares
AUB
$5.05B
| $3.72M | ﹤0.01% |
106,134
+5,149
| +5% | +$180K |
|
1308
Duolingo
DUOL
$14.1B
| $3.72M | ﹤0.01% |
26,056
-20,214
| -44% | -$2.88M |
|
1309
Grocery Outlet
GO
$1.74B
| $3.7M | ﹤0.01% |
130,767
+224
| +0.2% | +$6.33K |
|
1310
Hancock Whitney
HWC
$5.36B
| $3.69M | ﹤0.01% |
101,291
-1,686
| -2% | -$61.4K |
|
1311
Arcosa
ACA
$4.67B
| $3.69M | ﹤0.01% |
58,412
+7,605
| +15% | +$480K |
|
1312
Rhythm Pharmaceuticals
RYTM
$6.39B
| $3.68M | ﹤0.01% |
206,035
+163,838
| +388% | +$2.92M |
|
1313
Genworth Financial
GNW
$3.61B
| $3.66M | ﹤0.01% |
729,318
+22,416
| +3% | +$113K |
|
1314
Champion Homes, Inc.
SKY
$4.22B
| $3.66M | ﹤0.01% |
48,650
-5,624
| -10% | -$423K |
|
1315
PennyMac Financial
PFSI
$6.44B
| $3.65M | ﹤0.01% |
61,273
+2,526
| +4% | +$151K |
|
1316
AMC Entertainment Holdings
AMC
$1.44B
| $3.62M | ﹤0.01% |
72,275
-14,326
| -17% | -$718K |
|
1317
Innospec
IOSP
$2.05B
| $3.62M | ﹤0.01% |
35,251
+1,678
| +5% | +$172K |
|
1318
Kirby Corp
KEX
$4.8B
| $3.59M | ﹤0.01% |
51,441
-2,213
| -4% | -$154K |
|
1319
Vishay Intertechnology
VSH
$2.07B
| $3.58M | ﹤0.01% |
158,362
+16,226
| +11% | +$367K |
|
|
UCB
1320
United Community Banks, Inc.
UCB
$3.94B
| $3.58M | ﹤0.01% |
127,341
+7,299
| +6% | +$205K |
|
1321
Castle Biosciences
CSTL
$621M
| $3.57M | ﹤0.01% |
157,322
-1,741
| -1% | -$39.6K |
|
1322
PTC Therapeutics
PTCT
$4.85B
| $3.56M | ﹤0.01% |
73,490
+5,621
| +8% | +$272K |
|
|
AMED
1323
DELISTED
Amedisys
AMED
| $3.52M | ﹤0.01% |
+47,904
| New | +$3.52M |
|
1324
Array Technologies
ARRY
$1.17B
| $3.5M | ﹤0.01% |
159,839
+15,626
| +11% | +$342K |
|
1325
Tri Pointe Homes
TPH
$3.09B
| $3.5M | ﹤0.01% |
138,056
-13,098
| -9% | -$332K |
|